№ files_lp_4_process_3_132678
File format: docx Character count: 10301 File size: 729 KB
Supplementary materials detailing the methods, results, and analyses for the study of neoantigen heterogeneity in patients with resected intrahepatic cholangiocarcinoma, with a focus on genomic and immune profiling.
Year: 2026
Region / City: Not specified
Topic: Cancer research
Document type: Supplementary Materials
Institution: Not specified
Authors: Jianzhen Lin, Bo Hu, Yang Shi, Jiaqian Wang, Xu Yang, Weikang Hu, Xiaobo Yang, Xin Lu, Xinting Sang, Zhibo Gao, Ruibin Xi, Haitao Zhao
Target audience: Medical researchers, Oncologists
Period of validity: Not specified
Approval date: Not specified
Date of amendments: Not specified
Note: Contextual description
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Nine Non-evaluable Patients for Best Response Analysis in Cholangiocarcinoma and Gallbladder Carcinoma (2016–2019)
Year: 2016–2019
Region / Location: Multicenter clinical study
Disease Type: Cholangiocarcinoma, Gallbladder carcinoma
Patient Count: 9
Patient Sex: 5 female, 4 male
Age Range: 51–80
Metastatic Sites: Liver, lung, lymph nodes, peritoneum
Stage: 4
Treatment Type: Investigational therapy in clinical trial
Start Dates: 5/9/2016 – 11/20/2019
End Dates: 6/9/2017 – 12/19/2019
Reason for Discontinuation: Clinical decline, hospice, rapid progression, hospitalization, death, toxicity, gastrointestinal bleed
Follow-up Cut-off: 03/10/2021
Document Type: Clinical trial appendix table
Source: Study patient records
Survey on Adjuvant Chemotherapy and Radiotherapy for Incompletely Resected Early Stage NSCLC in Europe
Year: 2012
Region / City: Europe / Vienna
Theme: Lung Cancer, Oncology
Document Type: Survey
Organization / Institution: European Society for Medical Oncology (ESMO)
Author: Dr. Raffaele Califano
Target Audience: Medical Oncologists, Radiation Oncologists
Period of Action: Deadline end of February 2012
Approval Date: N/A
Date of Changes: N/A
Prognostic value of desmoplastic growth patterns in resected hepatocellular carcinoma
Year: 2022
Region / City: Oulu, Vaasa, Jyväskylä, Finland; Solna, Sweden
Topic: Hepatocellular carcinoma, Prognostic markers
Document type: Research Article
Institution: Oulu University Hospital, Karolinska Institutet
Authors: Niklas Sarelin, Valtteri Kairaluoma, Juha Saarnio, Joonas H. Kauppila, Jan Böhm, Heikki Huhta, Juha P. Väyrynen, Olli Helminen
Target audience: Medical researchers, oncologists, pathologists
Period of validity: N/A
Approval date: 2022
Modification date: N/A
Topics: Neoantigens Cholangiocarcinoma Resected